Aoxing Financial Statements From 2010 to 2025
| AOXG Stock | USD 0 0.00 0.00% |
Check Aoxing Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aoxing Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Aoxing financial statements analysis is a perfect complement when working with Aoxing Pharmaceutical Valuation or Volatility modules.
Aoxing |
Aoxing Pharmaceutical Company Current Valuation Analysis
Aoxing Pharmaceutical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aoxing Pharmaceutical Current Valuation | 1.43 M |
Most of Aoxing Pharmaceutical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aoxing Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Aoxing Pharmaceutical has a Current Valuation of 1.43 M. This is 99.99% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Aoxing Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aoxing Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Aoxing Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aoxing Pharmaceutical competition to find correlations between indicators driving Aoxing Pharmaceutical's intrinsic value. More Info.Aoxing Pharmaceutical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aoxing Pharmaceutical's earnings, one of the primary drivers of an investment's value.About Aoxing Pharmaceutical Financial Statements
Aoxing Pharmaceutical stakeholders use historical fundamental indicators, such as Aoxing Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aoxing Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aoxing Pharmaceutical's assets and liabilities are reflected in the revenues and expenses on Aoxing Pharmaceutical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aoxing Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the Peoples Republic of China. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China. Aoxing Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 346 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Aoxing Pink Sheet
Aoxing Pharmaceutical financial ratios help investors to determine whether Aoxing Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aoxing with respect to the benefits of owning Aoxing Pharmaceutical security.